人工角膜和角膜植入市场规模、份额、成长分析（按类型、按植入物类型、按适应症、按最终用户、按地区）- 行业预测，2025 年至 2032 年

2023 年全球人工角膜和角膜植入市场规模价值 4.542 亿美元，预计将从 2024 年的 4.8781 亿美元增长到 2032 年的 8.6355 亿美元，预计在预测期内到 2032 年将达到 14 亿美元（ 2025 -2026年）。

由于眼部疾病盛行率的上升和眼部保健投资需求的增加，人工角膜和角膜植入市场预计将显着增长。人们对眼角膜捐赠认识的不断提高和器官捐赠登记数量的激增进一步推动了市场扩张。此外，增加获得可靠的眼部移植手术的机会以及改善眼科护理的报销政策预计也将推动销售。然而，这些植入的高成本可能会阻碍某些地区的市场发展。值得注意的是，全球老年人口的快速成长对人工角膜和角膜植入产生了持续的需求，未来几年市场将呈现长期成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和资料资料
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

人工角膜和角膜植入市场规模（按类型）

• 市场概况
• 人类角膜
• 人工角膜

人工角膜和角膜植入市场规模（以植入物类型）

• 市场概况
• 穿透性角膜移植术
• 内皮角膜移植手术
• 前板层角膜移植手术
• 人工替代物

人工角膜和角膜植入市场规模（依适应症）

• 市场概况
• 福克斯营养不良症
• 霉菌性角膜炎
• 圆锥角膜
• 其他的

人工角膜和角膜植入市场规模（依最终用户）

• 市场概况
• 医院及门诊手术中心
• 专科门诊

人工角膜和角膜植入市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分析市场份额
  • 收益与前一年同期比较（2022-2024 年）

主要企业简介

• CorNeat Vision（Israel）
• KeraMed, Inc.（USA）
• LinkoCare Life Sciences AB（Sweden）
• DIOPTEX GmbH（Austria）
• EyeYon Medical（Israel）
• AJL Ophthalmic SA（Spain）
• Mediphacos（Brazil）
• CorneaGen（USA）
• Florida Lions Eye Bank（USA）
• San Diego Eye Bank（USA）
• Alabama Eye Bank（USA）
• Massachusetts Eye and Ear（USA）
• Advancing Sight Network（USA）
• LV Prasad Eye Institute（LVPEI, India）
• Alcon Inc.（Switzerland）
• Aurolab（India）
• Cornea Biosciences（USA）
• Price Vision Group（USA）

结论和建议

Global Artificial Cornea and Corneal Implant Market size was valued at USD 454.2 million in 2023 and is poised to grow from USD 487.81 million in 2024 to USD 863.55 million by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The artificial cornea and corneal implant market is anticipated to experience significant growth due to the rising prevalence of ophthalmic diseases and an increasing consumer willingness to invest in eye care. Heightened awareness of eye donation and a surge in organ donor registries are further fueling market expansion. Additionally, enhanced access to reliable eye transplant procedures and improved reimbursement policies for eye care are expected to drive sales. However, high costs associated with these implants in certain regions may hinder market development. Notably, the rapidly growing geriatric population worldwide will create sustained demand for artificial corneas and corneal implants, positioning the market for long-term growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Cornea And Corneal Implant market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Cornea And Corneal Implant Market Segmental Analysis

Global Artificial Cornea and Corneal Implant Market is segmented by Type, Transplant Type, Disease Indication, End User and region. Based on Type, the market is segmented into Human Cornea and Artificial Cornea. Based on Transplant Type, the market is segmented into Penetrating Keratoplasty, Endothelial Keratoplasty, Anterior lamellar keratoplasty and keratoprosthesis. Based on Disease Indication, the market is segmented into Fuchs' Dystrophy, Fungal Keratitis, Keratoconus and Others. Based on End User, the market is segmented into Hospitals & Ambulatory Surgical Centers and Specialty Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Artificial Cornea And Corneal Implant Market

The rising incidence of corneal disorders is a significant driver for the Global Artificial Cornea and Corneal Implant market. This increase can be attributed to both an aging population and greater exposure to screens, which have heightened the occurrence of these conditions globally. As the need for corneal transplants grows in response to these disorders, there will be an escalated demand for artificial corneas and corneal implants. Consequently, advancements in technology and medical procedures are expected to further spur market growth, addressing the needs arising from this escalating health concern.

Restraints in the Global Artificial Cornea And Corneal Implant Market

One significant constraint facing the Global Artificial Cornea and Corneal Implant market is the limited reimbursement options for corneal transplantation procedures. Many healthcare insurance plans do not comprehensively cover these surgeries, forcing patients to bear the high costs out-of-pocket. This financial burden often discourages individuals from pursuing such critical procedures, ultimately hindering market growth. The high expenses associated with corneal transplants create a barrier that could prevent broader accessibility and adoption, limiting the potential for advancements and expansions within the artificial cornea and implant sector. As a result, the market may struggle to thrive amid these financial challenges.

Market Trends of the Global Artificial Cornea And Corneal Implant Market

The Global Artificial Cornea and Corneal Implant market is increasingly trending towards the adoption of minimally invasive surgical techniques, as patients prioritize quicker recovery times and reduced surgical risks. This shift has prompted product developers to innovate and streamline their offerings, making advanced corneal solutions more accessible to both surgeons and patients. Additionally, enhancing reimbursement policies for these procedures is becoming critical, as it can significantly boost the uptake of artificial corneas and implants. As healthcare systems evolve to support these trends, market players must adapt their strategies to capitalize on the growing demand for effective, less invasive ocular treatments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Artificial Cornea and Corneal Implant Market Size by Type & CAGR (2025-2032)

• Market Overview
• Human Cornea
• Artificial Cornea

Global Artificial Cornea and Corneal Implant Market Size by Transplant Type & CAGR (2025-2032)

• Market Overview
• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Anterior lamellar keratoplasty
• keratoprosthesis

Global Artificial Cornea and Corneal Implant Market Size by Disease Indication & CAGR (2025-2032)

• Market Overview
• Fuchs' Dystrophy
• Fungal Keratitis
• Keratoconus
• Others

Global Artificial Cornea and Corneal Implant Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Ambulatory Surgical Centers
• Specialty Clinics

Global Artificial Cornea and Corneal Implant Market Size & CAGR (2025-2032)

• North America (Type, Transplant Type, Disease Indication, End User)
  • US
  • Canada
• Europe (Type, Transplant Type, Disease Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Transplant Type, Disease Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Transplant Type, Disease Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Transplant Type, Disease Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CorNeat Vision (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• KeraMed, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LinkoCare Life Sciences AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DIOPTEX GmbH (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EyeYon Medical (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AJL Ophthalmic SA (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediphacos (Brazil)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CorneaGen (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Florida Lions Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• San Diego Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alabama Eye Bank (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Massachusetts Eye and Ear (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advancing Sight Network (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L V Prasad Eye Institute (LVPEI, India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alcon Inc. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aurolab (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cornea Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Price Vision Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations